Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
NASDAQ:GH
Holding GH?
Track your performance easily
See the Price Targets and Ratings of:
GH Analyst Ratings
Strong Buy
14 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GH Stock 12 Month Forecast
Average Price Target
$43.08
▲(45.34% Upside)
| Highest Price Target$60.00 | Average Price Target$43.08 | Lowest Price Target$34.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Reiterated
11/11/24
Scotiabank
Reiterated
11/08/24
Craig-Hallum
Reiterated
11/07/24
TD Cowen
Assigned
11/07/24
Piper Sandler
Assigned
11/07/24
Goldman Sachs
Reiterated
11/07/24
J.P. Morgan
Reiterated
11/07/24
Stifel Nicolaus
Reiterated
11/07/24
Leerink Partners
Reiterated
11/07/24
BTIG
Reiterated
11/06/24
Canaccord Genuity
$42
Buy
41.70%
Upside
Reiterated
11/06/24
Guardant Health: Strong Buy Rating Backed by Robust Growth and Strategic Advancements
UBS
$32→$40
Buy
34.95%
Upside
Reiterated
08/21/24
Guardant Health price target raised to $40 from $32 at UBSGuardant Health price target raised to $40 from $32 at UBS
Jefferies
$32→$40
Buy
34.95%
Upside
Reiterated
08/08/24
Guardant Health (GH) PT Raised to $40 at JefferiesJefferies analyst Tycho Peterson raised the price target on Guardant Health (NASDAQ: GH) to $40.00 (from $32.00) while maintaining a Buy rating.
Citi
$40→$45
Buy
51.82%
Upside
Reiterated
08/08/24
Guardant Health price target raised to $45 from $40 at CitiGuardant Health price target raised to $45 from $40 at Citi
Best Analysts Covering Guardant Health
Which Analyst Should I Follow If I Want to Buy GH and Sell After:
1 Month
xxx
Success Rate
7/11 ratings generated profit
Average Return
+3.98%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.64% of your transactions generating a profit, with an average return of +3.98% per trade.
3 Months
xxx
Success Rate
7/12 ratings generated profit
Average Return
+7.34%
assigned a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +7.34% per trade.
1 Year
Success Rate
8/12 ratings generated profit
Average Return
+18.61%
assigned a buy rating 6 days ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +18.61% per trade.
2 Years
xxx
Success Rate
9/12 ratings generated profit
Average Return
+12.96%
assigned a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +12.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GH Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
8
4
5
8
10
Buy
22
25
21
15
7
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
29
26
23
17
Each month's total comprises the sum of three months' worth of ratings.
GH Financial Forecast
GH Stock Forecast FAQ
What is GH’s average 12-month price target, according to analysts?
Based on analyst ratings, Guardant Health’s 12-month average price target is $43.08.
What is GH’s upside potential, based on the analysts’ average price target?
Guardant Health has 45.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GH a Buy, Sell or Hold?
Guardant Health has a consensus rating of Strong Buy which is based on 14 buy ratings, 0 hold ratings and 0 sell ratings.
What is Guardant Health’s price target?
The average price target for Guardant Health is $43.08. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $60.00 ,the lowest forecast is $34.00. The average price target represents 45.34% Increase from the current price of $29.64.
The highest analyst price target is $60.00 ,the lowest forecast is $34.00. The average price target represents 45.34% Increase from the current price of $29.64.
What do analysts say about Guardant Health?
Guardant Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of GH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.